-logo-1200x675.png){kind=logo}
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report)’s share price rose 48.3% on Wednesday. The stock traded as high as $20.00 and last traded at $20.00. Approximately 100 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 729 shares. The stock had previously closed at $13.49.
CellaVision AB (publ) Stock Performance
The business has a 50 day moving average of $14.12 and a 200-day moving average of $14.67.
CellaVision AB (publ) Company Profile
CellaVision AB develops digital microscopy solutions for clinical laboratories, with a focus on blood cell analysis in hematology. Its systems help laboratory professionals examine and classify blood cells and support the review of cell morphology.
The company’s offerings combine automated imaging instruments with software for image analysis and review. These tools are designed to support laboratory workflows, including the assessment of blood-cell differentials, and can help specialists collaborate on results.
Founded in 1994 and headquartered in Lund, Sweden, CellaVision serves customers internationally through a global sales and distribution network.
Further Reading
- Five stocks we like better than CellaVision AB (publ)
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
